Floatz logo

DEXAMETHASONE

Hypersensitivity Reaction

Shanghai Pulmonary Hospital, Shanghai, ChinaSmall moleculePhase 4 / ApprovedActive
BBB
73/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
58/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Hypersensitivity Reaction cohort.

Asset / SponsorPhaseRating
Benadryl
Providence Health & Services
Phase 3B
CETIRIZINE
Providence Health & Services
Phase 3B
Miglustat
University of Florida
Phase 1CC

Same molecule, other indications

DEXAMETHASONE is also rated in:

chemotherapy-induced toxicityDormant
A
Indicative ·
82 / 100
View asset →
adult acute lymphoblastic leukemiaDormant
BBB
Indicative ·
79 / 100
View asset →
B-cell childhood acute lymphoblastic leukemiaDormant
BBB
Indicative ·
78 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →